SCHEMBL22720441

SCHEMBL22720441

Oc1ccccc1-c1nc(Cl)c2c(n1)CN(Cc1ccccc1)CC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
TSHR P16473 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KDM4E B2RXH2 1/20 0.49
GLA P06280 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
PARP1 P09874 1/20 0.47
TNKS2 Q9H2K2 1/20 0.47
PARP2 Q9UGN5 1/20 0.47
C5AR1 P21730 1/20 0.43
MEN1 O00255 2/20 0.43
STARD3 Q14849 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PNMT P11086 1/20 0.41
GRM2 Q14416 1/20 0.40
CFTR P13569 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5259551 0.87 KMT2A (0.50) KMT2AALDH1A1MAPTKDM4EGLA
SCHEMBL172736 0.84 BRS3 (0.48) KMT2AALDH1A1MAPTTSHRL3MBTL1
SCHEMBL5999914 0.84 KMT2A (0.54) KMT2AALDH1A1MAPTTSHRKDM4E
SCHEMBL22720440 0.84 KMT2A (0.49) KMT2AALDH1A1MAPTKDM4EGLA
SCHEMBL172809 0.83 C5AR1 (0.51) KMT2AALDH1A1MAPTTSHRKDM4E
SCHEMBL786788 0.83 KMT2A (0.47) KMT2AALDH1A1MAPTKDM4EGLA
SCHEMBL19959258 0.83 KMT2A (0.58) KMT2AALDH1A1MAPTKDM4EGLA
SCHEMBL29486422 0.83 KMT2A (0.58) KMT2AALDH1A1MAPTKDM4EGLA
SCHEMBL1831804 0.80 C5AR1 (0.60) KMT2AALDH1A1MAPTKDM4EGLA
SCHEMBL31095294 0.80 C5AR1 (0.60) KMT2AALDH1A1MAPTKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020239077-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海翰森生物医药科技有限公司 2020-12-03 WO disclosed